Latest IPC The Hospitalist Company (IPCM) Headlines
IPC The Hospitalist Company Announces 2013 Hospitalists of the Year
Business Wire - Tue Mar 11, 7:30AM CDT
IPC The Hospitalist Company, Inc. (NASDAQ: IPCM), a leading national physician group practice company, today announced the recipients for its 2013 Hospitalist of the Year award. The IPC awards program, now in its sixth year, recognizes IPC clinical leaders who have made outstanding contributions to the Company, to their facility and to the patients they serve, both in acute care and post-acute care settings. Selected by IPC's senior management team, this year's five award recipients are:
IPC the Hospitalist Company Acquires New York Post-Acute Practice
GlobeNewswire - Fri Mar 07, 9:23AM CST
IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician group practice company, announced today that it has acquired CAP Medical Group, PLLC, a post-acute hospitalist practice headquartered in New Hartford, New York. The acquisition represents an expansion for IPC in upstate New York, where the company already has an established presence. The CAP transaction is IPC's third acquisition in the state of New York in the past 18 months.
Quarterly and Annual Financial Results Release, Executive Appointments, Upcoming Conferences, and Promotion Announcements - Analyst Notes on NuVasive, IPC, Portola, ICU Medical, and Prothena
PR Newswire - Wed Mar 05, 7:32AM CST
Editor Note: For more information about this release, please scroll to bottom.
IPC The Hospitalist Down 11.5% Since SmarTrend Downtrend Call (IPCM)
Comtex SmarTrend(R) - Tue Mar 04, 9:15AM CST
SmarTrend identified a Downtrend for IPC The Hospitalist (NASDAQ:IPCM) on December 18th, 2013 at $57.72. In approximately 3 months, IPC The Hospitalist has returned 11.49% as of today's recent price of $51.09.
IPC The Hospitalist Company Names New Executive Director for Colorado
Business Wire - Mon Mar 03, 7:30AM CST
IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) announced today that it has appointed John H. Cassin to the position of Executive Director for the Company's Colorado region. In his new role, Cassin will be responsible for the operational supervision of IPC's Colorado regional services for both acute and post-acute care business. Additionally, he will be responsible for delivering on IPC's ongoing commitment to align its clinicians with the operational goals of client facilities and payers, while delivering high quality and cost-effective care to patients.
Lifshitz & Miller Law Firm Announces Investigation of Coty, Inc., Galena Biopharma, Inc., InnerWorkings, Inc., IPC The Hospitalist Company, Inc. and K12, Inc.
PR Newswire - Wed Feb 26, 4:06PM CST
Coty, Inc.
IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - Thu Feb 20, 3:01PM CST
IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician group practice, today announced financial results for the fourth quarter and full year ended December 31, 2013. All operating results referred to as "adjusted" exclude the change in fair market value of contingent consideration ("net change in fair value") for acquisitions. See "Reconciliation of Non-GAAP Financial Measures" below for explanations of these non-GAAP financial measures and reconciliation to GAAP financial measures.
IPC The Hospitalist Company, Inc. to Participate in Upcoming Investor Conferences
GlobeNewswire - Wed Feb 12, 7:30AM CST
IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician group practice, today announced that Adam Singer, M.D., chairman and chief executive officer, and Jeff Taylor, president and chief operating officer, are scheduled to present at the following investor conferences:
IPC The Hospitalist Company to Report Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - Fri Feb 07, 7:30AM CST
IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician group practice, will report its financial results for the fourth quarter and full year ended Dec. 31, 2013 on Thursday, Feb. 20, 2014, after the market close.
IPC THE HOSPITALIST INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates IPC The Hospitalist Company, Inc. Following Justice Department Intervention in False Claims Lawsuit
Business Wire - Thu Feb 06, 9:00PM CST
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq. a partner at the law firm of Kahn Swick & Foti, LLC ("KSF") announces that KSF has commenced an investigation into IPC The Hospitalist Company, Inc. (Nasdaq: IPCM).
Harwood Feffer LLP Announces Investigation of IPC The Hospitalist Company, Inc.
PR Newswire - Thu Feb 06, 7:30PM CST
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of IPC The Hospitalist Company, Inc. ("IPC" or the "Company") (NASDAQ: IPCM), concerning whether the board has breached its fiduciary duties to shareholders.
Robbins Arroyo LLP Is Investigating the Officers and Directors of IPC The Hospitalist Company, Inc. on Behalf of Shareholders
PR Newswire - Thu Feb 06, 2:21PM CST
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of the hospitalist services provider, IPC The Hospitalist Company, Inc. (NASDAQ: IPCM), breached their fiduciary duties to shareholders.
The Shuman Law Firm Investigates IPC The Hospitalist Company, Inc.
Business Wire - Tue Feb 04, 7:00PM CST
The Shuman Law Firm announces that it is investigating potential claims against certain officers and directors of IPC The Hospitalist Company, Inc. ("IPC" or the "Company") (IPCM). IPC is a California-based national physician group practice company that operates and manages full-time hospitalist practices.
Zeldes Haeggquist & Eck, LLP Announces Investigation of IPC The Hospitalist Company, Inc.
Business Wire - Wed Jan 29, 8:01AM CST
Zeldes Haeggquist & Eck, LLP, a shareholder and consumer rights litigation firm, has commenced an investigation into whether certain officers and directors at IPC The Hospitalist Company, Inc. ("IPC" or the "Company"), violated securities laws or breached their fiduciary duties to shareholders.
Earning Release Schedules and J.P. Morgan Healthcare Conference Presentation Schedules - Research Report on Cardinal Health, Ventas, Cerner, TESARO, and IPC
PR Newswire - Tue Jan 14, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting Cardinal Health, Inc. (NYSE: CAH), Ventas, Inc. (NYSE: VTR), Cerner Corporation (NASDAQ: CERN), TESARO, Inc. (NASDAQ: TSRO), and IPC The Hospitalist Company, Inc. (NASDAQ: IPCM). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Charles River Laboratories International (CRL) Jumps: Stock Up 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 08, 7:51AM CST
Charles River Laboratories International was a big mover last session, as its shares rose over 6% on the day.
IPC The Hospitalist Company to Present at J.P. Morgan Healthcare Conference
GlobeNewswire - Tue Jan 07, 7:30AM CST
IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician group practice, today announced that Adam Singer, M.D., chairman and chief executive officer, Jeff Taylor, president and chief operating officer, and Rick Kline, chief financial officer, are scheduled to present at the 32nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco.
Downgrade Alert for IPC The Hospitalist (IPCM)
Comtex SmarTrend(R) - Fri Jan 03, 7:09AM CST
IPC The Hospitalist (NASDAQ:IPCM) was downgraded from Outperform to Neutral at Credit Suisse today. The stock closed yesterday at $58.55 on volume of 118,000 shares, above average daily volume of 104,000. IPC The Hospitalist (NASDAQ:IPCM) is currently priced 9.3% above its average consensus analyst price target of $53.08. IPC The Hospitalist shares have support at the 50-day moving average (MA) of $58.42 and additional support at the 200-day MA of $51.60.
IPC The Hospitalist Company Graduates Third Group of Fellows in Hospitalist Leadership from UCSF
Business Wire - Mon Dec 23, 7:30AM CST
IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician practice company, announced today that the third cohort of its Practice Group Leaders have successfully completed the Fellowship in Hospitalist Leadership from the University of California, San Francisco (UCSF) Division of Hospital Medicine. A new group of 40 IPC physicians also started in the Fellowship program. Anticipated graduation for this class is November 2014, at which time there will be approximately 150 graduates of the IPC-UCSF Fellowship in a clinical leadership position in the company.
Positive Trial Results, Completed Acquisitions, and Clearances - Research Report on Dyax, IPC, Array BioPharma, Lexicon Pharmaceuticals, and Wright Medical
PR Newswire - Fri Dec 20, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
IPC The Hospitalist Company Announces 2013 Hospitalists of the Year
Business Wire - Tue Mar 11, 7:30AM CDT
IPC The Hospitalist Company, Inc. (NASDAQ: IPCM), a leading national physician group practice company, today announced the recipients for its 2013 Hospitalist of the Year award. The IPC awards program, now in its sixth year, recognizes IPC clinical leaders who have made outstanding contributions to the Company, to their facility and to the patients they serve, both in acute care and post-acute care settings. Selected by IPC's senior management team, this year's five award recipients are:
IPC the Hospitalist Company Acquires New York Post-Acute Practice
GlobeNewswire - Fri Mar 07, 9:23AM CST
IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician group practice company, announced today that it has acquired CAP Medical Group, PLLC, a post-acute hospitalist practice headquartered in New Hartford, New York. The acquisition represents an expansion for IPC in upstate New York, where the company already has an established presence. The CAP transaction is IPC's third acquisition in the state of New York in the past 18 months.
Quarterly and Annual Financial Results Release, Executive Appointments, Upcoming Conferences, and Promotion Announcements - Analyst Notes on NuVasive, IPC, Portola, ICU Medical, and Prothena
PR Newswire - Wed Mar 05, 7:32AM CST
Editor Note: For more information about this release, please scroll to bottom.
IPC The Hospitalist Down 11.5% Since SmarTrend Downtrend Call (IPCM)
Comtex SmarTrend(R) - Tue Mar 04, 9:15AM CST
SmarTrend identified a Downtrend for IPC The Hospitalist (NASDAQ:IPCM) on December 18th, 2013 at $57.72. In approximately 3 months, IPC The Hospitalist has returned 11.49% as of today's recent price of $51.09.
IPC The Hospitalist Company Names New Executive Director for Colorado
Business Wire - Mon Mar 03, 7:30AM CST
IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) announced today that it has appointed John H. Cassin to the position of Executive Director for the Company's Colorado region. In his new role, Cassin will be responsible for the operational supervision of IPC's Colorado regional services for both acute and post-acute care business. Additionally, he will be responsible for delivering on IPC's ongoing commitment to align its clinicians with the operational goals of client facilities and payers, while delivering high quality and cost-effective care to patients.
Lifshitz & Miller Law Firm Announces Investigation of Coty, Inc., Galena Biopharma, Inc., InnerWorkings, Inc., IPC The Hospitalist Company, Inc. and K12, Inc.
PR Newswire - Wed Feb 26, 4:06PM CST
Coty, Inc.
IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - Thu Feb 20, 3:01PM CST
IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician group practice, today announced financial results for the fourth quarter and full year ended December 31, 2013. All operating results referred to as "adjusted" exclude the change in fair market value of contingent consideration ("net change in fair value") for acquisitions. See "Reconciliation of Non-GAAP Financial Measures" below for explanations of these non-GAAP financial measures and reconciliation to GAAP financial measures.
IPC The Hospitalist Company, Inc. to Participate in Upcoming Investor Conferences
GlobeNewswire - Wed Feb 12, 7:30AM CST
IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician group practice, today announced that Adam Singer, M.D., chairman and chief executive officer, and Jeff Taylor, president and chief operating officer, are scheduled to present at the following investor conferences:
IPC The Hospitalist Company to Report Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - Fri Feb 07, 7:30AM CST
IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician group practice, will report its financial results for the fourth quarter and full year ended Dec. 31, 2013 on Thursday, Feb. 20, 2014, after the market close.
IPC THE HOSPITALIST INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates IPC The Hospitalist Company, Inc. Following Justice Department Intervention in False Claims Lawsuit
Business Wire - Thu Feb 06, 9:00PM CST
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq. a partner at the law firm of Kahn Swick & Foti, LLC ("KSF") announces that KSF has commenced an investigation into IPC The Hospitalist Company, Inc. (Nasdaq: IPCM).
Harwood Feffer LLP Announces Investigation of IPC The Hospitalist Company, Inc.
PR Newswire - Thu Feb 06, 7:30PM CST
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of IPC The Hospitalist Company, Inc. ("IPC" or the "Company") (NASDAQ: IPCM), concerning whether the board has breached its fiduciary duties to shareholders.
Robbins Arroyo LLP Is Investigating the Officers and Directors of IPC The Hospitalist Company, Inc. on Behalf of Shareholders
PR Newswire - Thu Feb 06, 2:21PM CST
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of the hospitalist services provider, IPC The Hospitalist Company, Inc. (NASDAQ: IPCM), breached their fiduciary duties to shareholders.
The Shuman Law Firm Investigates IPC The Hospitalist Company, Inc.
Business Wire - Tue Feb 04, 7:00PM CST
The Shuman Law Firm announces that it is investigating potential claims against certain officers and directors of IPC The Hospitalist Company, Inc. ("IPC" or the "Company") (IPCM). IPC is a California-based national physician group practice company that operates and manages full-time hospitalist practices.
Zeldes Haeggquist & Eck, LLP Announces Investigation of IPC The Hospitalist Company, Inc.
Business Wire - Wed Jan 29, 8:01AM CST
Zeldes Haeggquist & Eck, LLP, a shareholder and consumer rights litigation firm, has commenced an investigation into whether certain officers and directors at IPC The Hospitalist Company, Inc. ("IPC" or the "Company"), violated securities laws or breached their fiduciary duties to shareholders.
Earning Release Schedules and J.P. Morgan Healthcare Conference Presentation Schedules - Research Report on Cardinal Health, Ventas, Cerner, TESARO, and IPC
PR Newswire - Tue Jan 14, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting Cardinal Health, Inc. (NYSE: CAH), Ventas, Inc. (NYSE: VTR), Cerner Corporation (NASDAQ: CERN), TESARO, Inc. (NASDAQ: TSRO), and IPC The Hospitalist Company, Inc. (NASDAQ: IPCM). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Charles River Laboratories International (CRL) Jumps: Stock Up 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 08, 7:51AM CST
Charles River Laboratories International was a big mover last session, as its shares rose over 6% on the day.
IPC The Hospitalist Company to Present at J.P. Morgan Healthcare Conference
GlobeNewswire - Tue Jan 07, 7:30AM CST
IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician group practice, today announced that Adam Singer, M.D., chairman and chief executive officer, Jeff Taylor, president and chief operating officer, and Rick Kline, chief financial officer, are scheduled to present at the 32nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco.
Downgrade Alert for IPC The Hospitalist (IPCM)
Comtex SmarTrend(R) - Fri Jan 03, 7:09AM CST
IPC The Hospitalist (NASDAQ:IPCM) was downgraded from Outperform to Neutral at Credit Suisse today. The stock closed yesterday at $58.55 on volume of 118,000 shares, above average daily volume of 104,000. IPC The Hospitalist (NASDAQ:IPCM) is currently priced 9.3% above its average consensus analyst price target of $53.08. IPC The Hospitalist shares have support at the 50-day moving average (MA) of $58.42 and additional support at the 200-day MA of $51.60.
IPC The Hospitalist Company Graduates Third Group of Fellows in Hospitalist Leadership from UCSF
Business Wire - Mon Dec 23, 7:30AM CST
IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician practice company, announced today that the third cohort of its Practice Group Leaders have successfully completed the Fellowship in Hospitalist Leadership from the University of California, San Francisco (UCSF) Division of Hospital Medicine. A new group of 40 IPC physicians also started in the Fellowship program. Anticipated graduation for this class is November 2014, at which time there will be approximately 150 graduates of the IPC-UCSF Fellowship in a clinical leadership position in the company.
Positive Trial Results, Completed Acquisitions, and Clearances - Research Report on Dyax, IPC, Array BioPharma, Lexicon Pharmaceuticals, and Wright Medical
PR Newswire - Fri Dec 20, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
